Luxempart S A : Conversion of Luxempart bearer shares into dematerialized shares Appointment of LuxCSD S.A. as settlement organisation
April 26, 2023 at 02:09 am EDT
Share
Siège Social:
12 rue Léon Laval L-3372 Leudelange
R.C.S. Luxembourg B 27846
www.luxempart.lu
PRESS RELEASE
Conversion of Luxempart bearer shares into dematerialized shares
Appointment of LuxCSD S.A. as settlement organisation
Leudelange, April 26, 2023
On April 24, 2023, the Extraordinary General Meeting of shareholders of Luxempart has approved the conversion of bearer shares issued by Luxempart into dematerialized shares.
The Board of Directors of Luxempart has decided to appoint LuxCSD S.A., a public limited company whose registered office is located at 42, Avenue J.F. Kennedy L - 1855 Luxembourg, registered with the Luxembourg Registre de Commerce et des Sociétés (RCS) under number B154449, as "organisme de liquidation" (settlement organisation), in accordance with the Law of April 6, 2013 relating to dematerialized securities as amended.
The dematerialization will be effective within three months after the publication of a dedicated notice to the RCS.
A FAQ explaining the main features of this dematerialization is available to shareholders and all other interested persons.
Luxempart is a Luxembourg-based listed investment company with a net worth of EUR 2.2bn backed by Luxembourgish entrepreneurial families. With permanent capital and a professional investment team, Luxempart provides flexible long-term financing solutions to entrepreneurs, families and management and actively supports its portfolio companies in their growth and international expansion.
Luxempart's Direct Investment strategy consists in investing equity tickets ranging from EUR 25m up to EUR 100m in the DACH region, France, BeLux and Northern Italy.
Luxempart SA published this content on 26 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 April 2023 06:06:04 UTC.
Luxempart SA is a Luxembourg-based investment company which invests in listed and private equity, as well as in private equity funds. The Company is active in Luxembourg, Belgium, France, Italy and Germany, where it manages a portfolio of listed and unlisted companies. Through Luxempart Capital Partners and Indufin Capital Partners (ICP), Luxempart also runs private equity activities. ICP is a joint-venture with the Belgian family holding Eik NV. The Company holds stakes in a number of private companies, including SES, RTL Group, Atenor, Foyer Finance, Foyer SA, SEO, PNE Wind, Pescanova, Mirato, Indufin Capital Partners - ICP Sicar, IEE, Quip, DS Care, Ekkio Capital, Thrombogenics, IP Sante domicile, Octopede Fonds private equity, among others. It also holds a majority stake in Euphaco (ABC Chemical).
LUXEMPART S.A. 
